Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
25%(1 trials)

Phase Distribution

Ph phase_3
4
80%

Phase Distribution

0

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
4(100.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(4)
Terminated(1)

Detailed Status

Completed4
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 34 (100.0%)

Trials by Status

withdrawn120%
completed480%

Recent Activity

0 active trials
Showing 5 of 5
withdrawn

Patient-reported Outcomes in Subjects Treated With ReFacto AF Routine Prophylaxis

NCT02718677
completedphase_3

Study Evaluating B-Domain Deleted Recombinant Factor VIII (BDDrFVIII, ReFacto AF) in Patients With Hemophilia A Undergoing Elective Major Surgery

NCT00243659
completedphase_3

Study Evaluating BDDRFVIII and ReFacto AF in Hemophilia A

NCT00038935
completedphase_3

Study Evaluating ReFacto AF in Severe Hemophilia A

NCT00037544
completedphase_3

Study to Establish Bioequivalence of ReFacto AF (BDDrFVIII) With Advate (FLrFVIII) in Hemophilia A

NCT00141843

Clinical Trials (5)

Showing 5 of 5 trials
NCT02718677

Patient-reported Outcomes in Subjects Treated With ReFacto AF Routine Prophylaxis

Withdrawn
NCT00243659Phase 3

Study Evaluating B-Domain Deleted Recombinant Factor VIII (BDDrFVIII, ReFacto AF) in Patients With Hemophilia A Undergoing Elective Major Surgery

Completed
NCT00038935Phase 3

Study Evaluating BDDRFVIII and ReFacto AF in Hemophilia A

Completed
NCT00037544Phase 3

Study Evaluating ReFacto AF in Severe Hemophilia A

Completed
NCT00141843Phase 3

Study to Establish Bioequivalence of ReFacto AF (BDDrFVIII) With Advate (FLrFVIII) in Hemophilia A

Completed

All 5 trials loaded

Drug Details

Intervention Type
GENETIC
Total Trials
5